Answers are grounded in this paper and cite their sources.
Introduction: Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), which can lead to chronic infection and expose affected individuals to a high risk of complications, particularly cirrhosis and hepatocellular carcinoma. This study characterised the virological profile of HBsAg-positive patients in Mauritania: HBV DNA replication levels, the most affected sex and age groups, and the geographical distribution of patients. Methods: This descriptive cross-sectional study included 1,263 HBsAg-positive patients whose plasma HBV DNA was quantified by real-time PCR at the National Institute of Public Health Research, Nouakchott, from January 2019 to December 2020. Viral load was categorised as low (<2,000 IU/mL), intermediate (2,000–20,000 IU/mL) or high (>20,000 IU/mL). Associations were tested with Pearson’s chi-square test. Results: HBV DNA was detected in 894 patients (70.8%), with no difference by sex (p = 0.18). Overall, 93 patients (7.4%) had high, 132 (10.5%) intermediate and 1,038 (82.2%) low HBV DNA replication; intermediate and high replication were more frequent in men (p = 0.0041). The median viral load was 126 IU/mL (IQR 20–961), and its distribution differed between age groups (p = 0.0201). PCR-positive and high-replication patients were concentrated in Nouakchott, Trarza, Brakna and Hodh Ech Chargui. Conclusion: Most HBsAg-positive patients had low HBV DNA replication, but about one in thirteen had high replication, more often in men. Systematic viral load monitoring should be integrated into the national hepatitis control programme to identify patients requiring treatment and to prevent severe complications.
No takes yet. Share an insight, caveat, or question.
Hachmi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: